Substance use disorders and the harms associated with these diseases are a serious, growing public health problem in the United States. Nearly 19,000 Americans died from prescription opioid overdoses in 2014, and more than 10,500 people died from overdoses of heroin. In total, this translates to 78 lives lost each day from an opioid overdose.
Yet these deaths do not reflect the full public health impact of substance use disorders. Individuals who misuse drugs or alcohol are more likely to develop chronic health conditions, experience poorer health outcomes, and have contact with the criminal justice system. The costs are high: The National Institute on Drug Abuse estimates that illicit drug and alcohol abuse accounts for more than $400 billion annually related to health care, lost work productivity, and crime.
More than 21 million Americans have a substance use disorder. However, in 2014, only about 10 percent of these individuals received any kind of treatment—whether through self-help programs, inpatient and outpatient treatment centers, or doctors’ offices. Effective care, including access to programs that provide medication-assisted treatment, remains elusive for many patients.
Public health experts and policymakers are now calling for evidence-based strategies to prevent substance misuse and improve treatment options for people with substance use disorders. As part of this effort, Pew’s substance use prevention and treatment initiative develops and supports state and federal policies that would:
- Reduce the inappropriate use of prescription drugs while ensuring that patients have access to effective pain management.
- Expand access to effective treatment for substance use disorders, including through the increased use of drug and behavioral health therapies.
Our WorkView All
Prescription drug monitoring programs (PDMPs) are state-run electronic databases that collect information on controlled substances dispensed to patients. They are intended to help health care providers safely prescribe and monitor the use of certain drugs, including opioid pain relievers. Specifically, they seek to reduce “multiple provider episodes” (when patients visit numerous health care... Read More
Every September, the Substance Abuse and Mental Health Services Administration (SAMHSA) sponsors National Recovery Month, an opportunity for people to learn more about substance use disorders (SUD) and celebrate those who are recovering from their disease. As the nation’s prescription and illicit opioid crisis has demonstrated, these disorders are devastating illnesses that can affect... Read More